Cvs Group Stock Fair Value – Can CVS Group plc’s (LON:CVSG) Stock Rebound After Recent Weakness?

March 31, 2023

Trending News 🌧️

In recent weeks, CVS ($LSE:CVSG) Group plc’s stock has weakened and investors are wondering if this trend is likely to be short-lived given its strong fundamentals. With a strong balance sheet and a resilient business model, the company looks well-positioned to manage any further shocks to the economy caused by the pandemic. CVS Group plc also has fantastic prospects for growth in the coming years, with an extensive pipeline of new veterinary practices and a strategy of launching new services into existing practices. The company is also continuing to expand its veterinary diagnostics offering, which provides a steady stream of revenue through service contracts.

Overall, CVS Group plc appears to have strong underlying fundamentals and sounds like it could be primed for a rebound in its stock price after the recent weakness. With a strong balance sheet, healthy operating profits, and good prospects for growth, the company looks well placed to weather any further shocks from the pandemic and continue to provide its high-quality services to customers.

Market Price

CVS Group plc (LON: CVSG) has recently experienced a period of stock weakness, but on Monday it showed signs of rebounding. Despite opening at £18.3, the stock closed at £18.4, indicating an increase of 0.7% from the previous closing price of 18.3. This could be a sign that CVS Group is poised to bounce back from recent volatility and stabilize its stock performance. It remains uncertain as to whether or not CVS Group can sustain its current momentum, but there are encouraging signs that the company is working to improve its stock performance. For example, the company has been actively restructuring, which could help to strengthen the value of its stock.

Additionally, CVS Group has been exploring new, innovative strategies to capture market share and expand its customer base, which could provide a further boost to its stock. Overall, CVS Group appears to be taking the necessary steps to ensure a successful rebound from its recent weakness. With the right strategies in place, and continued focus on improving stock performance, CVS Group could be well-positioned for future success. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Cvs Group. More…

    Total Revenues Net Income Net Margin
    576.8 29.3 5.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Cvs Group. More…

    Operations Investing Financing
    81.3 -58.7 -17
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Cvs Group. More…

    Total Assets Total Liabilities Book Value Per Share
    527.7 293.8 3.28
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Cvs Group are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    9.8% 27.2% 8.3%
    FCF Margin ROE ROA
    8.2% 13.2% 5.6%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Cvs Group Stock Fair Value

    As part of our analysis of CVS GROUP‘s wellbeing, we at GoodWhale conducted a detailed valuation of the company. After thorough analysis, we have calculated the fair value of CVS GROUP share to be around £19.2 using our proprietary Valuation Line model. Currently, CVS GROUP stock is traded at £18.4, which appears to be a fair price but is slightly undervalued by 4.1%. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    It has a strong presence in the veterinary services industry, competing against other established players such as Motorpoint Group PLC, Mulberry Group PLC, and XPS Pensions Group PLC. CVS Group PLC is well positioned to continue delivering value and growth to its customers and shareholders.

    – Motorpoint Group PLC ($LSE:MOTR)

    Motorpoint Group PLC is a leading automotive retailing group offering customers a wide selection of new and nearly new cars from a range of leading manufacturers. The company operates from 11 locations in the UK, stocking over 6,000 vehicles at any one time. As of 2022, Motorpoint Group PLC had a market capitalization of 130.78M, reflecting its strong position in the automotive retailing market. The company has also demonstrated a strong return on equity of 24.69%, indicating that it is well managed and is efficiently utilizing its resources to generate returns for its shareholders.

    – Mulberry Group PLC ($LSE:MUL)

    Mulberry Group PLC is a luxury fashion company that designs and manufactures handbags, accessories and clothing. The company has a market capitalization of 138.18 million as of 2022, which makes it a mid-sized player in the luxury goods industry. Its Return on Equity (ROE) of 16.19% signals a strong performance, with the company performing better than the industry average. Mulberry Group mainly operates in the U.K. and Europe, but has distribution outlets in countries like the United States, Japan, China, and South Korea. The company has been able to generate steady profits and stable returns for investors through its strategic investments in product innovation, marketing and distribution.

    – XPS Pensions Group PLC ($LSE:XPS)

    XPS Pensions Group PLC is a global provider of pension services, offering professional advice and support to employers, trustees, and members on a range of pension related matters. As of 2022, the company has a market capitalization of 290.42M, indicating the company’s strong performance in the pension services industry. Its Return on Equity (ROE) of 8.08% indicates that the company is able to generate a good return on its investment in the business, making it an attractive investment option for those looking for a reliable and secure pension provider.

    Summary

    Investors have been closely watching CVS Group plc’s (LON:CVSG) stock performance in recent months. Despite the stock’s recent weakness, the company has strong fundamentals, such as long-term growth potential, a solid balance sheet, strong cash flow, and a competitive dividend yield. Analysts are generally positive about the company’s prospects, noting that its competitive advantages, global presence, and focus on innovation should benefit shareholders in the long term.

    Investors should carefully evaluate the risks associated with investing in CVS Group plc, such as changing economic conditions, competitive pressures, and industry risks. Nevertheless, with a sound financial position and a healthy business outlook, investors should consider the stock as a potential long-term investment opportunity.

    Recent Posts

    Leave a Comment